MD, MHS, MBA
Professor, Neurology
Deputy Director of Research
Chief Scientific Officer
UNC Lineberger Comprehensive Cancer Center
UNC-Chapel Hill
UNC Health
Cancer Cell Biology Research Program
Area of Interest
Jeremy Rich, MD, MHS, MBA, is Deputy Director for Research and Chief Scientific Officer of the UNC Lineberger Comprehensive Cancer Center, and Professor of Neurology at the University of North Carolina at Chapel Hill.
Dr. Rich’s Laboratory identifies novel therapeutic paradigms in the treatment of advanced cancers, primarily malignant brain tumors, through the prism of stem cell biology to identify core regulatory pathways amenable to pharmacologic targeting. His team aims to better understand the clinical relevance of cancer stem cells and the interaction with the tumor microenvironment and underlying genetic driver mutations in human cancers.
His laboratory has made contributions in several areas, including therapeutic resistance, circadian rhythm, cancer epigenetics, tumor microenvironment, epitranscriptomics, tumor organoids/bioprinting, cancer metabolism, and cancer metabolism.
A driving force in his NIH-funded research efforts is leveraging patient-derived tissues and collaborations with other research groups with complementary expertise.
Awards and Honors
- Highly Cited Researchers (Top 1%), Web of Science, Clarivate Analytics, 2025
News and Stories
UNC Lineberger hosts inaugural Innovate Cancer Data Science Symposium
Researchers, clinicians, data scientists and trainees gathered for the inaugural UNC Lineberger Innovate Cancer Data Science Symposium, a daylong event highlighting the rapid evolution of AI, genomics and data‑driven tools shaping the future of cancer care.
UNC Lineberger researchers among world’s most influential in Clarivate 2025 Highly Cited Researchers list
Eleven UNC Lineberger Comprehensive Cancer Center members were named as 2025 Highly Cited Researchers by Clarivate for publishing some of the most influential scientific papers during the past decade.
